CaltechAUTHORS
  A Caltech Library Service

Evaluation of artificial signal peptides for secretion of two lysosomal enzymes in CHO cells

Cheng, Kai-Wen and Wang, Feng and Lopez, George A. and Singamsetty, Srikanth and Wood, Jill and Dickson, Patricia I. and Chou, Tsui-Fen (2021) Evaluation of artificial signal peptides for secretion of two lysosomal enzymes in CHO cells. Biochemical Journal, 478 (12). pp. 2309-2319. ISSN 0264-6021. doi:10.1042/bcj20210015. https://resolver.caltech.edu/CaltechAUTHORS:20210723-172036186

Full text is not posted in this repository. Consult Related URLs below.

Use this Persistent URL to link to this item: https://resolver.caltech.edu/CaltechAUTHORS:20210723-172036186

Abstract

Enzyme replacement therapy (ERT) is a scientifically rational and clinically proven treatment for lysosomal storage diseases. Most enzymes used for ERT are purified from the culture supernatant of mammalian cells. However, it is challenging to purify lysosomal enzymes with sufficient quality and quantity for clinical use due to their low secretion levels in mammalian cell systems. To improve the secretion efficiency of recombinant lysosomal enzymes, we evaluated the impact of artificial signal peptides on the production of recombinant lysosomal enzymes in Chinese hamster ovary (CHO) cell lines. We engineered two recombinant human lysosomal enzymes, N-acetyl-α-glucosaminidase (rhNAGLU) and glucosamine (N-acetyl)-6-sulfatase (rhGNS), by replacing their native signal peptides with nine different signal peptides derived from highly secretory proteins and expressed them in CHO K1 cells. When comparing the native signal peptides, we found that rhGNS was secreted into media at higher levels than rhNAGLU. The secretion of rhNAGLU and rhGNS can, however, be carefully controlled by altering signal peptides. The secretion of rhNAGLU was relatively higher with murine Igκ light chain and human chymotrypsinogen B1 signal peptides, whereas Igκ light chain signal peptide 1 and human chymotrypsinogen B1 signal peptides were more effective for rhGNS secretion, suggesting that human chymotrypsinogen B1 signal peptide is the most appropriate for increasing lysosomal enzyme secretion. Collectively, our results indicate that altering signal peptide can modulate the secretion of recombinant lysosome enzymes and will enable lysosomal enzyme production for clinical use.


Item Type:Article
Related URLs:
URLURL TypeDescription
https://doi.org/10.1042/bcj20210015DOIArticle
ORCID:
AuthorORCID
Cheng, Kai-Wen0000-0001-9888-9773
Chou, Tsui-Fen0000-0003-2410-2186
Additional Information:© 2021 The Author(s). Published by Portland Press Limited on behalf of the Biochemical Society. Received: January 12 2021; Revision Received: May 24 2021; Accepted: May 24 2021; Accepted Manuscript online: May 25 2021.
Subject Keywords:N-acetyl-α-glucosaminidase (NAGLU), enzyme replacement therapy, mucopolysaccharidosis, N-acetylglucosamine-6-sulfatase (GNS), signal peptide
Issue or Number:12
DOI:10.1042/bcj20210015
Record Number:CaltechAUTHORS:20210723-172036186
Persistent URL:https://resolver.caltech.edu/CaltechAUTHORS:20210723-172036186
Official Citation:Kai-Wen Cheng, Feng Wang, George A. Lopez, Srikanth Singamsetty, Jill Wood, Patricia I. Dickson, Tsui-Fen Chou; Evaluation of artificial signal peptides for secretion of two lysosomal enzymes in CHO cells. Biochem J 25 June 2021; 478 (12): 2309–2319. doi: https://doi.org/10.1042/BCJ20210015
Usage Policy:No commercial reproduction, distribution, display or performance rights in this work are provided.
ID Code:109997
Collection:CaltechAUTHORS
Deposited By: Tony Diaz
Deposited On:26 Jul 2021 19:05
Last Modified:26 Jul 2021 19:05

Repository Staff Only: item control page